C4 Therapeutics CCCC
NASDAQ CCCC
$3.27 -0.06 (-1.95%)
As of: Oct 1, 2026 · 12:51 PM EDT

C4 Therapeutics (CCCC) Return on Equity [ROE] (2020 - 2026)

Updated

C4 Therapeutics (CCCC) reported Return on Equity [ROE] of -42.07% for Q2 2026, up 18.37 percentage points from -60.44% a year earlier and up 0.17 percentage points from the prior quarter.

Analysis

C4 Therapeutics (CCCC) Return on Equity [ROE] (2020 - 2026) Analysis & Trends

For FY2025, C4 Therapeutics posted Return on Equity [ROE] of -44.44%, up 1.15 percentage points from FY2024.

  • Return on Equity [ROE] has a five-year change of +34.15 percentage points (FY2020 to FY2025).
  • By year, Return on Equity [ROE] came in at -45.58% in FY2024 (+3.92 pp), -49.50% in FY2023 (-11.73 pp), -37.76% in FY2022 (-12.74 pp) and -25.03% in FY2021 (+53.56 pp).
  • The Q2 2026 figure ranks as the highest quarterly Return on Equity [ROE] since Q4 2022.
  • Year over year, Return on Equity [ROE] gained in four of the last eight quarters, with an average year-over-year change of +0.27 percentage points.
  • The high point for year-over-year Return on Equity [ROE] in five years was Q4 2021 (a gain of 84.97 percentage points); the low point was Q3 2025 (a drop of 29.42 percentage points).
  • Per Business Quant data, the three quarters before Q2 2026 came in at -42.25% (Q1 2026), -51.03% (Q4 2025) and -72.51% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 25.32%
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 7.21%
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 84.40%
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 21.39%
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 83.75%
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -18.38%
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 4.97%
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 22.24%
10 C4 Therapeutics 409.28 Mn -520.48 Mn - -42.07%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -42.07%
Mar 31, 2026 -42.25%
Dec 31, 2025 -51.03%
Sep 30, 2025 -72.51%
Jun 30, 2025 -60.44%
Mar 31, 2025 -50.24%
Dec 31, 2024 -45.93%
Sep 30, 2024 -43.09%
Jun 30, 2024 -42.69%
Mar 31, 2024 -49.99%
Dec 31, 2023 -57.34%
Sep 30, 2023 -60.00%
Jun 30, 2023 -56.37%
Mar 31, 2023 -47.42%
Dec 31, 2022 -42.03%
Sep 30, 2022 -32.02%
Jun 30, 2022 -27.88%
Mar 31, 2022 -25.07%
Dec 31, 2021 -21.28%
Sep 30, 2021 -22.09%
API Access

C4 Therapeutics Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=CCCC&period=max&api_key=YOUR_API_KEY